WOODCLIFF LAKE, NJ, Nov. 20, 2020 (GLOBE NEWSWIRE) -- NewMediaWire -- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announced that it has signed waiver agreements with certain of its existing institutional investors.
Read more here:
Timber Pharmaceuticals Signs Waiver Agreement with Warrant Holders
- 001 Eton Pharmaceuticals Announces Closing of Public Offering [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 002 Mydecine Innovations Group Appoints Boustead Capital Markets LLP as Financial Advisor for its Planned Dual Listing on the London Stock Exchange [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 003 Agios Announces Withdrawal of European Marketing Authorization Application for TIBSOVO® as a Treatment for Relapsed or Refractory IDH1-mutant Acute... [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 004 Stabilization measures taken [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 005 Coherus BioSciences Announces New Employment Inducement Grants [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 006 Biomerica Reports Fiscal 2021 1st Quarter Financial Results [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 007 Y-mAbs Announces Update on Naxitamab and Omburtamab in Neuroblastoma [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 008 German Federal Joint Committee (G-BA) Issues Nationwide Reimbursement Decision for EndoPredict® Breast Cancer Prognostic Test [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 009 SPACs Show Investors Faster, Simpler Way to Go Public [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 010 Psychedelics Experiencing Renaissance, Offer Tremendous Treatment Potential [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 011 Spero Therapeutics to Present Data for All Pipeline Programs at IDWeek 2020 [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 012 Zogenix Receives Positive CHMP Opinion for FINTEPLA® (Fenfluramine) Oral Solution for the Treatment of Seizures in Patients with Dravet Syndrome [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 013 Beyond Air® Presents Positive New Preclinical Data for the Use of a Single Injection of Gaseous Nitric Oxide as a Novel In situ Cancer Vaccination [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 014 CHMP recommends approval of Dupixent® (dupilumab) for children aged 6 to 11 years with severe atopic dermatitis [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 015 Novartis receives positive CHMP opinion for Leqvio®* (inclisiran), a potential first-in-class siRNA for the treatment of high cholesterol [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 016 Aimmune Receives Positive CHMP Opinion on PALFORZIA® for the Treatment of Patients with Peanut Allergy in Europe [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 017 Theratechnologies Appoints Two New Board Members [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 018 Nephros Announces Pricing of $5 Million Registered Direct Offering of Common Stock [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 019 First Patient Dosed in Phase II Trial to Treat Complications in COVID-19 [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 020 Cantor Fitzgerald and Kristen Kluska to Host Zoom Fireside Chat with Ocugen [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
- 021 Tauriga Sciences, Inc. Updates Shareholders on New York State's Determination to Allow the Sale of CBD Edibles in the Forms of Food & Drink [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 022 Zenith Confirms Interim Filings on SEDAR [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 023 Trading by management and close relations of management [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 024 AXIM® Biotechnologies Issues Update Letter to Shareholders [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 025 One World’s Dr. Kenneth Perego Joins Montel Williams for Blunt Discussion [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 026 Yield10 Bioscience Announces Start of Field Tests of Winter Camelina Varieties [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 027 Pandion Therapeutics Highlights Potential of Modular Biologics Pipeline for the Treatment of Autoimmune Diseases at FOCIS 2020 [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 028 Scout Bio Advances Novel Gene Therapy for the Treatment of Feline Diabetes [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 029 Rhythm Pharmaceuticals Appoints Jennifer Chien as Executive Vice President, Head of North America [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 030 Kane Biotech builds upon successful results with launch of a US Consumer Test [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 031 VYNE Therapeutics to Report Third Quarter 2020 Financial Results on November 5th [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 032 CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2020 Financial Results [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 033 BetterLife Provides Important Update on its Australian Clinical Study Design [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 034 Iovance Biotherapeutics to Present at Upcoming Conferences in November [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 035 Otonomy to Report Third Quarter 2020 Financial Results and Provide Corporate Update [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 036 OpGen Announces Award of German Government Grant Funding to its Subsidiary Curetis and Collaborators [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 037 Verona Pharma plc : Update on AIM Delisting [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 038 Kraig Biocraft Laboratories Delivers Recombinant Spider Silk Silkworm Eggs to Production Facility in Vietnam [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 039 G1 Therapeutics to Provide Third Quarter 2020 Corporate and Financial Update on November 4, 2020 [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 040 MediPharm Labs Sets Date to Release Third Quarter 2020 Financial Results [Last Updated On: October 28th, 2020] [Originally Added On: October 28th, 2020]
- 041 MediciNova Announces Presentation of Positive Findings on MN-001 (tipelukast) in Acute Liver Injury Model at The Liver Meeting Digital Experience™... [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 042 Aileron Therapeutics Reports Third Quarter 2020 Financial Results and Business Highlights [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 043 PLx Pharma Inc. 2020 Third Quarter Financial Results and Business Update Conference Call Rescheduled to November 16, 2020 [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 044 Timber Pharmaceuticals Provides Business Update and Announces Third Quarter 2020 Financial Results [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 045 Processa Pharmaceuticals Announces Third Quarter 2020 Results, Provides Corporate Update [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 046 EXMceuticals Provides Bi-Weekly Default Status Report [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 047 T2 Biosystems to Participate in the Canaccord Genuity Virtual MedTech & Diagnostics Forum [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 048 Tonix Pharmaceuticals Outlines New Statistical Method to Analyze Future PTSD Studies at the 3rd Annual Neuropsychiatric Drug Development Summit [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 049 Agios Announces FDA Orphan Drug Designation Granted to Mitapivat for Treatment of Sickle Cell Disease [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 050 ERYTECH to Present at Jefferies Virtual Healthcare Conference [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 051 Osmotica Pharmaceuticals plc to Present at 2020 Jefferies Virtual London Healthcare Conference [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 052 Harpoon Therapeutics Presents Encouraging Preclinical Data for HPN601 EpCAM ProTriTAC™ Program at 35th SITC Annual Meeting [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 053 Vaxcyte Reports Third Quarter 2020 Financial Results and Provides Business Update [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 054 Ovid Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 055 Berkeley Lights Reports Financial Results for Third Quarter of Fiscal Year 2020 [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 056 Sun BioPharma, Inc. Provides Business Update and Reports Q3 2020 Financial Results [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 057 Annexon Expands Classical Complement Platform into Neurodegenerative Diseases of the Brain with Initiation of Huntington’s Disease Clinical Program [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 058 ImmuCell Announces Unaudited Financial Results for the Third Quarter Ended September 30, 2020 [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 059 Neuronetics to Present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 060 Retrophin Completes Acquisition of Orphan Technologies [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- 061 Resverlogix Files Notice of Annual and Special Meeting of Shareholders [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 062 Zenith Files Notice of Annual and Special Meeting of Shareholders [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 063 LifeSci Acquisition II Corp. Announces Pricing of $75 Million Initial Public Offering [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 064 Chalice Farms to Launch “Holiday in Color” Pre-Roll Packs, Festive Promotions through Holiday Season [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 065 Auris Medical Launches Website for AM-301-focused Subsidiary, Altamira Medica [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 066 BioDelivery Sciences to Participate in the Piper Sandler 32nd Annual Healthcare Conference [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 067 Chiasma to Host an Expert Panel on Acromegaly and the MPOWERED® Phase 3 Trial Results [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 068 Praxis Precision Medicines to Participate in Upcoming Investor Conferences [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 069 Galera Therapeutics to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 070 Aditxt Appoints Anthony Voorhies as Head of Business Development for AditxtScore™ [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 071 Black Diamond Therapeutics Provides Update on GBM Program and Presents Pre-Clinical Data at the 2020 SNO Annual Meeting [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 072 Todos Medical Announces Positive In Vitro Data for Tollovid™ Confirming 3CL Protease Inhibition Mechanism of Action [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 073 Harrow Health Announces Participation at the Piper Sandler 32nd Annual Healthcare Conference [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 074 New Test for Triaging Preeclampsia Passes Key Development Milestone: Progenity Releases Prospective Clinical Verification Data for its Preecludia™... [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 075 Adaptimmune to Showcase Market Potential for SPEAR T-cell Portfolio and Pipeline with Multiple Cell Therapy Platforms During Virtual Investor Day [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 076 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 077 Trevena, Inc. Announces Publication Highlighting GI Tolerability Profile of OLINVYK™ (oliceridine) injection in Pain and Therapy [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 078 BioRestorative Therapies Emerges from Chapter 11 Reorganization [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 079 BioCryst to Present at Upcoming Virtual Investment Conferences [Last Updated On: November 22nd, 2020] [Originally Added On: November 22nd, 2020]
- 080 GW Pharmaceuticals to Present at the Evercore ISI 2020 Healthcare Conference [Last Updated On: November 30th, 2020] [Originally Added On: November 30th, 2020]